CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases (HITM-SIR)

Couldn't let Cafa break all the new trails to us!

(unless I've missed this one)
it's a phase 1b safety trail.

https://clinicaltrials.gov/ct2/show/NCT02416466?term=Sirtex Medical&rank=9

Safety of CAR-T cell hepatic artery infusions in combination with Sir-Spheres as Measured by Number of Participants with Adverse Events [ Time Frame: 14 weeks ] [ Designated as safety issue: Yes ]
To determine the safety and regimen limiting toxicity (RLT) of a standard of care treatment with Yttrium-90 Sir-Spheres Microspheres when following anti-CEA CAR-T hepatic artery infusions (HAI) for CEA-expressing liver metastases.